Universal Labs Opportunity Fund (co-managed by Pacifica Management Corporation and R&R Holdings) is a life sciences technology venture capital OZ fund with a mission to accelerate the commercialization of natural medicines that have demonstrated real-world efficacy preventing and treating chronic health conditions, including cancer, opioid addiction, PTSD, migraines, multiple sclerosis, and rheumatoid arthritis.
The fund plans to make 8-12 initial business investments, ranging in size from $1 million to $5 million, plus 3-5 real estate acquisitions.